Coronary vascular function was quantified in all patients using a whole-body PET/computed tomography scanner (PET/CT Discovery RX or STE LightSpeed 64, GE Healthcare, Milwaukee, WI). Myocardial blood flow (MBF, in mL/min/g) was measured at rest and during maximal hyperemia by a standard intravenous infusion of adenosine, dipyridamole or regadenoson using either 13N-ammonia or 82Rubidium as the flow tracers, as described previously.14 (link) The image acquisition and post processing techniques for quantification of myocardial blood flow (MBF) and flow reserve did not change over the study period. Previous studies have demonstrated that equivalence of dipyridamole, regadenoson, and adenosine as vasodilators for myocardial perfusion imaging and quantitative myocardial blood flow.15 (link), 16 (link) Furthermore, the use of different vasodilator stress agents has not affected the value of quantitative myocardial blood flow by PET for risk stratification.15 (link), 17 (link)-19 (link) The heart rate, blood pressure, and 12-lead electrocardiogram were recorded at baseline and every minute during and after the vasodilator infusion.